If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Cialis ® (tadalafil) tablets
2.5 mg, 5 mg, 10mg, 20 mg tablets
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
How to switch treatment from alpha blocker therapy to Cialis® (tadalafil) in patients with benign prostatic hyperplasia?
Patients on alpha blocker therapy for benign prostatic hyperplasia (BPH) should stop the alpha blocker at least one day before starting Cialis (tadalafil) for once-daily use for the treatment of BPH.
Prescribing Information
The efficacy of the coadministration of an alpha blocker and tadalafil for the treatment of benign prostatic hyperplasia (BPH) has not been adequately studied.1
As the potential vasodilatory effects of combined use could result in lowered blood pressure, the combination of tadalafil and alpha blockers is not recommended for the treatment of BPH.1
Patients on alpha blocker therapy for BPH should discontinue their alpha blocker at least 1 day prior to starting tadalafil for once-daily use for the treatment of BPH.1
Enclosed Prescribing Information
Reference
1Cialis [package insert]. Indianapolis, IN: Eli Lilly and Company; 2023.
Date of Last Review: June 01, 2023